TIANYIN PHARMACEUTICAL
TPI
TPI was delisted on the 29th of April, 2016.
5 hedge funds and large institutions have $297K invested in TIANYIN PHARMACEUTICAL in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
16% less capital invested
Capital invested by funds: $352K → $297K (-$55K)
44% less funds holding
Funds holding: 9 → 5 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$3.3K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$18K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$6K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$3K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$434 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $124K | +$3.3K | +24,800 | +3% |
|
|
PAM
2
Pope Asset Management
Memphis,
Tennessee
| $111K | – | – | – |
|
3
California Public Employees Retirement System
Sacramento,
California
| $53K | – | – | – |
|
|
CHP
4
Cable Hill Partners
Portland,
Oregon
| $8K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $1K | -$434 | -3,263 | -39% |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$18K | -108,025 | Closed |
|
|
VKH
7
Virtu KCG Holdings
New York
| – | -$6K | -37,981 | Closed |
|
|
8
Creative Planning
Overland Park,
Kansas
| – | -$3K | -20,000 | Closed |
|
TPI Hedge Fund Activity: Q1 2016 in Review
5 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in TIANYIN PHARMACEUTICAL (TPI) for Q1 2016, worth a combined $297K — down 16% from $352K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TPI and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $3.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $18K sold.
- 5 institutional investors held TIANYIN PHARMACEUTICAL (TPI) as of Q1 2016, down from 9 in Q4 2015.
- Funds reported $297K of TIANYIN PHARMACEUTICAL stock for Q1 2016, down 16% quarter-over-quarter.
- 0 funds opened new TIANYIN PHARMACEUTICAL positions in Q1 2016 and 4 closed out, a net change of -4 holders.
- The largest TIANYIN PHARMACEUTICAL buyer in Q1 2016 was Renaissance Technologies, an estimated $3.3K added.
- The largest TIANYIN PHARMACEUTICAL seller in Q1 2016 was Citadel Advisors, an estimated $18K sold.
Based on aggregated 13F filings for Q1 2016.